Share on StockTwits

pSivida Corp (NASDAQ:PSDV) CEO Paul Ashton unloaded 11,800 shares of the company’s stock on the open market in a transaction dated Friday, June 13th. The stock was sold at an average price of $4.02, for a total value of $47,436.00. Following the completion of the sale, the chief executive officer now directly owns 440,741 shares in the company, valued at approximately $1,771,779. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Separately, analysts at MLV & Co
initiated coverage on shares of pSivida Corp in a research note on Monday, May 5th. They set a “buy” rating and a $6.00 price target on the stock. One research analyst has rated the stock with a hold rating and three have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $5.43.

pSivida Corp (NASDAQ:PSDV) opened at 4.01 on Wednesday. pSivida Corp has a 52 week low of $2.28 and a 52 week high of $5.60. The stock has a 50-day moving average of $3.73 and a 200-day moving average of $3.94. The company’s market cap is $117.3 million.

pSivida Corp (NASDAQ:PSDV) last issued its quarterly earnings data on Tuesday, May 13th. The company reported ($0.03) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.15) by $0.12. The company had revenue of $2.00 million for the quarter, compared to the consensus estimate of $0.55 million. On average, analysts predict that pSivida Corp will post $-0.69 earnings per share for the current fiscal year.

pSivida Corp. develops drug delivery products that are administered by implantation, injection or insertion.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.